Results 1 to 10 of about 204,238 (313)

Suicide Risk in Glioblastoma Multiforme: A Brief Review of Risk Factors, Screening, and Prevention. [PDF]

Curr Psychiatry Rep
Waldvogel N, Ryu H, Riba M.
europepmc   +1 more source

Matrix stress relaxation drives glioblastoma cell response in viscoelastic biomaterials. [PDF]

Sci Adv
Ghorbani S, Huang MS, Zhang D, Liu Y, Long C, Zwetsloot R, Mozipo EAT, Rao RR, Enejder A, Heilshorn SC.   +9 more
europepmc   +1 more source

Interplay of Glioblastoma Cells with Microglia Shapes Invasive Phenotypes during Long-distance Invasion. [PDF]

Cancer Res
Friedel RH, Zou H.
europepmc   +1 more source

PSMA-Targeted Theranostics in Glioblastoma Multiforme: Current Evidence and Future Perspectives. [PDF]

Int J Mol Sci
Russo F, Ricci M, Dadgar H, Travascio L, De Feo MS, Brunotti G, Usmani S, Arabi H, Anwar FM, Khalaf AN, Filippi L, Cimini A.   +11 more
europepmc   +1 more source

Long non-coding RNAs in glioblastoma: from molecular drivers to therapeutic targets. [PDF]

Front Immunol
Elemam NM, Sweillam JH, El-Sherif Y, Youssef YA, Ismail HM, Assal RA, Youness RA.   +6 more
europepmc   +1 more source

p53 Pathway-Targeted Therapeutic Strategies in Glioblastoma: A CNS-Specific Framework Integrating Therapeutic Resistance, Molecular Stratification, CNS Pharmacology, and Clinical Translation. [PDF]

Drug Des Devel Ther
Bu F, Zeng S, Ma C, Zhang M.
europepmc   +1 more source

Sequential EGFR inhibition sensitizes glioblastoma to temozolomide. [PDF]

Trends Pharmacol Sci
Yu X, Wu R, Cheng SY.
europepmc   +1 more source

Sexual Dimorphism of ZEB1 Expression and Function in Glioblastoma. [PDF]

Cells
Whittaker BE, Davies S, Kwan JCF, Gordon-Smith A, Siebzehnrubl FA.   +4 more
europepmc   +1 more source

GBM-Antikörper [PDF]

, 2019
openaire   +1 more source

Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets. [PDF]

Future Sci OA
Li W, Chen JM, Ma YC.
europepmc   +1 more source